Hepatic hemangioma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Hepatic hemangioma}} | {{Hepatic hemangioma}} | ||
{{CMG}};{{AE}}{{NM}} | {{CMG}};{{AE}}{{NM}} | ||
==Overview== | |||
==Pathophysiology== | ==Pathophysiology== | ||
Revision as of 13:52, 20 October 2015
Hepatic hemangioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatic hemangioma pathophysiology On the Web |
American Roentgen Ray Society Images of Hepatic hemangioma pathophysiology |
Risk calculators and risk factors for Hepatic hemangioma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Pathophysiology
- They arise from the endothelial cells that line the blood vessels and consists of multiple, large vascular channels lined by a single layer of endothelial cells and supported by collagenous walls.
- They may be associated with focal nodular hyperplasia.
Associated Conditions
- May be associated with Kasabach-Merritt syndrome, hemolytic anemia and consumptive coagulopathy.